| PERIOD ENDING | 31-Jan-09 | 2-Feb-08 | 3-Feb-07 | | Total Revenue | 24,892,000 | 26,313,000 | 26,970,000 | | Cost of Revenue | 15,009,000 | 15,677,000 | 16,197,000 | | | Gross Profit | 9,883,000 | 10,636,000 | 10,773,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 8,481,000 | 8,554,000 | 8,678,000 | | Non Recurring | 5,780,000 | 219,000 | 259,000 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (4,378,000) | 1,863,000 | 1,836,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 28,000 | 36,000 | 61,000 | | Earnings Before Interest And Taxes | (4,350,000) | 1,899,000 | 1,897,000 | | Interest Expense | 588,000 | 579,000 | 451,000 | | Income Before Tax | (4,938,000) | 1,320,000 | 1,446,000 | | Income Tax Expense | (135,000) | 411,000 | 458,000 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,803,000) | 909,000 | 988,000 | | | Non-recurring Events | | Discontinued Operations |
-
| (16,000) | 7,000 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (4,803,000) | 893,000 | 995,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,803,000) | $893,000 | $995,000 |
|
0.49% Nasdaq 0.00%
Income Statement
